SCHEMBL6557142

SCHEMBL6557142

CC1CC(=O)NN=C1c1ccc2c(NCc3ccccc3)ncnc2c1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PDE3B Q13370 5/20 1.00
▸ PDE3A Q14432 5/20 1.00
▸ EGFR P00533 5/20 0.50
▸ GPR119 Q8TDV5 5/20 0.48
▸ LMNA P02545 4/20 0.48
▸ TSHR P16473 2/20 0.48
▸ MAPK1 P28482 2/20 0.48
▸ USP2 O75604 1/20 0.48
▸ ALDH1A1 P00352 1/20 0.48
▸ CYP1A2 P05177 1/20 0.48
▸ CYP3A4 P08684 1/20 0.48
▸ CYP2D6 P10635 1/20 0.48
▸ CYP2C9 P11712 1/20 0.48
▸ CYP2C19 P33261 1/20 0.48
▸ HIF1A Q16665 1/20 0.48
▸ HSD17B10 Q99714 1/20 0.48
▸ CLK4 Q9HAZ1 1/20 0.48
▸ GALR3 O60755 2/20 0.47
▸ NR2F2 P24468 2/20 0.47
▸ RAB9A P51151 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7276596 0.86 PDE3B (0.75) PDE3BPDE3AGPR119BRD4
SCHEMBL7266756 0.84 PDE3B (0.71) PDE3BPDE3AGPR119GALR3
SCHEMBL7268541 0.80 PDE3B (0.67) PDE3BPDE3AEGFRLMNATSHR
SCHEMBL7276740 0.79 PDE3B (0.64) PDE3BPDE3AGPR119GALR3
SCHEMBL7307881 0.78 PDE3B (0.63) PDE3BPDE3AGPR119GALR3BRD4
SCHEMBL16491995 0.78 PDE3B (0.64) PDE3BPDE3AGPR119ALDH1A1GALR3
SCHEMBL7276606 0.77 PDE3B (0.64) PDE3BPDE3AGPR119LMNAMAPK1
SCHEMBL7275405 0.77 PDE3B (0.62) PDE3BPDE3AGPR119GALR3
SCHEMBL7275287 0.77 PDE3B (0.62) PDE3BPDE3AGPR119GALR3
SCHEMBL2592062 0.77 PDE3B (0.62) PDE3BPDE3AGPR119ALDH1A1GALR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1176960-B1 SYNERGISTIC COMBINATION COMPRISING ROFLUMILAST AND A PDE-3 INHIBITOR ALTANA PHARMA AG (DE) 2004-09-29 — — EP claimed
EP-1176960-B1 SYNERGISTIC COMBINATION COMPRISING ROFLUMILAST AND A PDE-3 INHIBITOR ALTANA PHARMA AG (DE) 2004-09-29 — — EP disclosed
Send feedback